Reply to “Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!”

Saved in:
Bibliographic Details
Published in:Cancer 2023-07, Vol.129 (14), p.2268-2268
Main Authors: Haddad, Fadi G., Bidikian, Aram, Issa, Ghayas C.
Format: Article
Language:English
Subjects:
Chronic myeloid leukemia
Humans
Kinases
Leukemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myeloid
Myeloid leukemia
Obesity
Obesity - complications
Obesity - surgery
Oncology
Protein Kinase Inhibitors - pharmacology
Protein Kinase Inhibitors - therapeutic use
Tyrosine
Tyrosine Kinase Inhibitors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c3164-9c30a4badfe2d7c7bb79ddafb20d2c11bf2febcec9db2961d924201213134b313
container_end_page 2268
container_issue 14
container_start_page 2268
container_title Cancer
container_volume 129
creator Haddad, Fadi G.
Bidikian, Aram
Issa, Ghayas C.
description
doi_str_mv 10.1002/cncr.34834
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2809543059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2828276576</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3164-9c30a4badfe2d7c7bb79ddafb20d2c11bf2febcec9db2961d924201213134b313</originalsourceid><addsrcrecordid>eNp9kc1qFEEQxxtRzCZ68QGkxEsQNvbH7M6ON1mMBoJCUPA29EeN20lP96S7J8vc8iD6Ej5SnsReN3rwIAVVVPGrP0X9CXnG6AmjlL_WXscTUa1E9YDMGG3qOWUVf0hmlNLVfFGJrwfkMKXL0tZ8IR6TA1EzsRJ1NSM_L3BwE-QAd7ffz_pB6gyhg6Aw2TxBGuM3jBMED3mKIVmPcGW9TAjWb6yyOUSImIbgEyaQ3uxWbuyNdBDGrENfptbDILNFnxNsbd6A3sTgrYZ-QhesAYfjFfZWvoHTMeYNRjAyS5ARIWXrHGxljNJnNC_ubn88IY866RI-va9H5Mvpu8_rD_PzT-_P1m_P51qwZTVvtKCyUtJ0yE2ta6XqxhjZKU4N14ypjneoNOrGKN4smWl4xSnjTDBRqZKOyPFed4jhesSU294mjc5Jj2FMLV_RpjyXLpqCvvwHvQxj9OW6QpWol4t6WahXe0qXT6aIXTtE28s4tYy2OyfbnZPtbycL_PxeclQ9mr_oH-sKwPbA1jqc_iPVrj-uL_aivwAhVq-E</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2828276576</pqid></control><display><type>article</type><title>Reply to “Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!”</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>EZB Electronic Journals Library</source><creator>Haddad, Fadi G. ; Bidikian, Aram ; Issa, Ghayas C.</creator><creatorcontrib>Haddad, Fadi G. ; Bidikian, Aram ; Issa, Ghayas C.</creatorcontrib><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.34834</identifier><identifier>PMID: 37138374</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Chronic myeloid leukemia ; Humans ; Kinases ; Leukemia ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy ; Leukemia, Myeloid ; Myeloid leukemia ; Obesity ; Obesity - complications ; Obesity - surgery ; Oncology ; Protein Kinase Inhibitors - pharmacology ; Protein Kinase Inhibitors - therapeutic use ; Tyrosine ; Tyrosine Kinase Inhibitors</subject><ispartof>Cancer, 2023-07, Vol.129 (14), p.2268-2268</ispartof><rights>2023 American Cancer Society.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3164-9c30a4badfe2d7c7bb79ddafb20d2c11bf2febcec9db2961d924201213134b313</cites><orcidid>0000-0002-4339-8683 ; 0000-0001-5856-5926 ; 0000-0002-9702-8485</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37138374$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haddad, Fadi G.</creatorcontrib><creatorcontrib>Bidikian, Aram</creatorcontrib><creatorcontrib>Issa, Ghayas C.</creatorcontrib><title>Reply to “Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!”</title><title>Cancer</title><addtitle>Cancer</addtitle><subject>Chronic myeloid leukemia</subject><subject>Humans</subject><subject>Kinases</subject><subject>Leukemia</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</subject><subject>Leukemia, Myeloid</subject><subject>Myeloid leukemia</subject><subject>Obesity</subject><subject>Obesity - complications</subject><subject>Obesity - surgery</subject><subject>Oncology</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Tyrosine</subject><subject>Tyrosine Kinase Inhibitors</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9kc1qFEEQxxtRzCZ68QGkxEsQNvbH7M6ON1mMBoJCUPA29EeN20lP96S7J8vc8iD6Ej5SnsReN3rwIAVVVPGrP0X9CXnG6AmjlL_WXscTUa1E9YDMGG3qOWUVf0hmlNLVfFGJrwfkMKXL0tZ8IR6TA1EzsRJ1NSM_L3BwE-QAd7ffz_pB6gyhg6Aw2TxBGuM3jBMED3mKIVmPcGW9TAjWb6yyOUSImIbgEyaQ3uxWbuyNdBDGrENfptbDILNFnxNsbd6A3sTgrYZ-QhesAYfjFfZWvoHTMeYNRjAyS5ARIWXrHGxljNJnNC_ubn88IY866RI-va9H5Mvpu8_rD_PzT-_P1m_P51qwZTVvtKCyUtJ0yE2ta6XqxhjZKU4N14ypjneoNOrGKN4smWl4xSnjTDBRqZKOyPFed4jhesSU294mjc5Jj2FMLV_RpjyXLpqCvvwHvQxj9OW6QpWol4t6WahXe0qXT6aIXTtE28s4tYy2OyfbnZPtbycL_PxeclQ9mr_oH-sKwPbA1jqc_iPVrj-uL_aivwAhVq-E</recordid><startdate>20230715</startdate><enddate>20230715</enddate><creator>Haddad, Fadi G.</creator><creator>Bidikian, Aram</creator><creator>Issa, Ghayas C.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4339-8683</orcidid><orcidid>https://orcid.org/0000-0001-5856-5926</orcidid><orcidid>https://orcid.org/0000-0002-9702-8485</orcidid></search><sort><creationdate>20230715</creationdate><title>Reply to “Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!”</title><author>Haddad, Fadi G. ; Bidikian, Aram ; Issa, Ghayas C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3164-9c30a4badfe2d7c7bb79ddafb20d2c11bf2febcec9db2961d924201213134b313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chronic myeloid leukemia</topic><topic>Humans</topic><topic>Kinases</topic><topic>Leukemia</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy</topic><topic>Leukemia, Myeloid</topic><topic>Myeloid leukemia</topic><topic>Obesity</topic><topic>Obesity - complications</topic><topic>Obesity - surgery</topic><topic>Oncology</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Tyrosine</topic><topic>Tyrosine Kinase Inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haddad, Fadi G.</creatorcontrib><creatorcontrib>Bidikian, Aram</creatorcontrib><creatorcontrib>Issa, Ghayas C.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haddad, Fadi G.</au><au>Bidikian, Aram</au><au>Issa, Ghayas C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reply to “Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!”</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2023-07-15</date><risdate>2023</risdate><volume>129</volume><issue>14</issue><spage>2268</spage><epage>2268</epage><pages>2268-2268</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>37138374</pmid><doi>10.1002/cncr.34834</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-4339-8683</orcidid><orcidid>https://orcid.org/0000-0001-5856-5926</orcidid><orcidid>https://orcid.org/0000-0002-9702-8485</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 2023-07, Vol.129 (14), p.2268-2268
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_2809543059
source Wiley-Blackwell Read & Publish Collection; EZB Electronic Journals Library
subjects Chronic myeloid leukemia
Humans
Kinases
Leukemia
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myeloid
Myeloid leukemia
Obesity
Obesity - complications
Obesity - surgery
Oncology
Protein Kinase Inhibitors - pharmacology
Protein Kinase Inhibitors - therapeutic use
Tyrosine
Tyrosine Kinase Inhibitors
title Reply to “Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!”
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A57%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reply%20to%20%E2%80%9CImpact%20of%20obesity%20surgery%20on%20tyrosine%20kinase%20inhibitor%20responses%20and%20survival%20outcomes%20in%20patients%20with%20chronic%20myeloid%20leukemia:%20Further%20data%20are%20still%20warranted!%E2%80%9D&rft.jtitle=Cancer&rft.au=Haddad,%20Fadi%20G.&rft.date=2023-07-15&rft.volume=129&rft.issue=14&rft.spage=2268&rft.epage=2268&rft.pages=2268-2268&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.34834&rft_dat=%3Cproquest_cross%3E2828276576%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3164-9c30a4badfe2d7c7bb79ddafb20d2c11bf2febcec9db2961d924201213134b313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2828276576&rft_id=info:pmid/37138374&rfr_iscdi=true